Search
for
Sort by
Research 541–570 of 1000+
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges
- Public Interest in JAK Inhibitors for Alopecia Areata: A Google Trend Analysis (Preprint)
- Can oral minoxidil be the game changer in androgenetic alopecia? A comprehensive review and meta-analysis comparing topical and oral minoxidil for treating androgenetic alopecia
- Global online interest in finasteride sexual side effects
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- Off-label prescriptions: patient safety first
- Alopecia – New building blocks
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- What to Look for in Red Light Therapy: A Product Guide Backed by Science
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Alopecia Areata: An Updated Review for 2023
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Ritlecitinib in severe alopecia areata: a profile of its use
- Coming full circle (almost): Low dose oral minoxidil for alopecia
- New Drugs: Dutasteride
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Topikal Retinoidler
- Novel agents for the treatment of alopecia
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases